Sunday March 25, 2018 06:23

Food and Healthcare Press Releases

Photo Release: BIG supports five hospitals with one million baht worth of medical equipment Heathcare—23 Mar 18

Bangkok Industrial Gas Co., Ltd. (BIG) celebrated its 30th anniversary with the corporate social responsibility campaign of "BIG's 30th Anniversary … Innovative Benefaction for Society" inspired by His Majesty the late King Rama IX 's royal

Semaglutide Injection Phase 2 Data Presented at ENDO Demonstrated Significant Weight Loss in Adults With Obesity Heathcare—20 Mar 18

CHICAGO--20 Mar--PRNewswire/InfoQuest
Oral session #12

Adults with obesity treated with semaglutide 0.4 mg administered once-daily via subcutaneous injections lost up to 13.8% of their body weight after 52 weeks in a phase 2 trial, significantly more than those treated with placebo who lost 2.3% of their body weight.[1] An oral presentation of data from this trial investigating the safety and efficacy of semaglutide as a potential treatment for adults with obesity took place at the Endocrine Society's annual meeting in Chicago (ENDO).

The results were from a phase 2, 52-week double blind dose-ranging study of once-daily semaglutide versus placebo and liraglutide 3 mg as active control. All trial participants also received dietary and physical exercise counselling.[1]

In the trial, 83% of people treated with semaglutide 0.4 mg lost greater than or equal to 5% of their body weight (compared to 23% with placebo and 66% with liraglutide 3 mg) and 65% lost greater than or equal to 10% (compared to 10% with placebo and 34% with liraglutide 3 mg).[1]

"In the US alone, more than 90 million adults have obesity. We need to continue to research and develop new therapies to support those living with this chronic disease," said Dr Patrick O'Neil of the Medical University of South Carolina and lead investigator. "I am

FDI Global Survey Shows Children are not Getting Dental Check-ups Early Heathcare—20 Mar 18

On the occasion of World Oral Health Day, FDI World Dental Federation asked parents around the world how they cared for their children's oral health growing up and the responses suggest room for improvement. Maintaining a healthy mouth is crucial to

Texas Cardiac Arrhythmia Institute at St. David#s Medical Center draws cardiac experts from across Heathcare—19 Mar 18

On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its fourth international symposium on complex arrhythmias, EPLive 2018. Nearly 200 leaders in the field of electrophysiology (EP) from Europe, Asia

Johnson Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Heathcare—19 Mar 18

Johnson & Johnson (NYSE: JNJ) today announced that it has received a binding offer from Platinum Equity, a leading private investment firm, to acquire its LifeScan business for approximately $2.1 billion, subject to customary adjustments. LifeScan,

Biotherm Hosts the First Biotherm Healing Summit Heathcare—16 Mar 18

Biotherm hosted the first "Biotherm Healing Summit" on March 7. A symposium on the theme of skin & healing, focusing on major research that has evidenced the link between micro-organisms and skin health. Unveiling Life PlanktonTM, the healing

Cardiologist Reccomends Top 3 Steps to Help Prevent Heart Disease in Heathcare—15 Mar 18

Bangkok, In Thailand, an average of 150 people per day, or six people per hour die from heart disease according to the Ministry of Public Health who reported that from 2012 to 2016, the average number of deaths caused by heart disease was approximately

Pilatus Clinical Services - German Subsidiary PCS GMBH Awarded WDL GDP Heathcare—14 Mar 18

As part of Pilatus Clinical Services ongoing plans to strengthen its position in Europe and as part of establishing a Global footprint, the company has announced that following a recent inspection by the German regulatory authorities, its German

Smartphone-based Retinal Imaging Together With Artificial Intelligence Powers Automated, Sensitive Heathcare—13 Mar 18

A new study published in the international Nature Eye Journal demonstrates very high sensitivity for detecting Diabetic Retinopathy (DR) (95.8%) and Sight-threatening DR (99.1%) using Remidio's Fundus on Phone (FOP) device - an FDA 510k registered and CE

Menarini Hires Their 17,000th Employee Heathcare—13 Mar 18

The 17,000th employee at Menarini is Lara, 28 years old, a young graduate in Chemistry and Pharmaceutical Technology from the University of Florence, who is now employed in Menarini Ricerche. (Photo:

The Menarini Group Announced Marketing Authorization Application for Heathcare—12 Mar 18

The Menarini Group announced today that on March 6th 2018 it submitted a Marketing Authorization Application for delafloxacin at the European Medicines Agency (EMA) under the trade name Quofenix. The proposed indication for delafloxacin in Europe is the

Berlinger Resolves Medium-term Withdrawal From the Doping Control Kit Business but Pledges to Help Heathcare—12 Mar 18

The Board of Directors of Berlinger Special AG has resolved that the company will cease production of its doping control kits in the medium term. To avoid jeopardizing current anti-doping activities, the company will continue to supply its present

ViiV Healthcare Announces Positive New Dolutegravir Data for the Treatment of People Living With Heathcare—06 Mar 18

INSPIRING study results contribute to the extensive body of evidence for dolutegravir, the leading integrase strand transfer inhibitor, in diverse and hard to treat patient populations ViiV Healthcare, the global specialist HIV company, majority owned

WH Dentalwerk Buermoos GmbH: WH Acquires Swedish Specialist Osstell Heathcare—02 Mar 18

W&H President and CEO Peter Malata announced the acquisition of the Swedish medical technology company Osstell AB on 1st March 2018. This purchase continues the international growth of the Austrian family-owned company W&H Dentalwerk Buermoos

Goodscend#s Vitamin K2 Landed in New York Times Square and Paris Fifteen District, Delivering the Heathcare—28 Feb 18

At the beginning of 2018, Goodscend Pharm. Sci & Tech. Co., Ltd. ("Goodscend") promoted its vitamin brand K2 on the large billboards overlooking New York's Times Square and in the 15th arrondissement of Paris. Vitamin K2 is recognized by the global

Texas Cardiac Arrhythmia Institute at St. David#s Medical Center to host EPLive Heathcare—26 Feb 18

On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its fourth international symposium on complex arrhythmias, EPLive 2018. EPLive is an intensive, two-day educational meeting for practicing

Israel Ministry of Health Includes INSIGHTEC#s Focused Ultrasound Treatment for Heathcare—21 Feb 18

INSIGHTEC(R), a commercial-stage medical technology company revolutionizing surgery with incisionless MR-guided focused ultrasound (MRgFUS) announced today that the Neuravive focused ultrasound treatment will be a covered service for essential tremor

The ImplantCenter Marks a New Era in the Hungarian Private Dental Service Heathcare—20 Feb 18

The ImplantCenter has recently opened the brand-new operating room suited for more complex treatments. This comes alongside numerous additions such as the launch of the four cosy apartments to rest after treatments at the clinic and an implant education

Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Heathcare—16 Feb 18

Merck and Pfizer Inc. (NYSE: PFE) today announced results from the Phase III JAVELIN Lung 200 trial comparing avelumab* to docetaxel in patients with unresectable, recurrent or metastatic non-small cell lung cancer (NSCLC) whose disease progressed after

PharmaMar Licenses Fully Synthetic Marine-derived Payloads to Seattle Genetics for Use in Drug Heathcare—15 Feb 18

PharmaMar (MCE: PHM) has announced today the signing of an exclusive licensing agreement with Seattle Genetics Inc. (SGEN: NASDAQ GS) under which Seattle Genetics receives exclusive worldwide rights to certain PharmaMar proprietary molecules for the

After multiple failed procedures at other medical institutions, Colorado man successfully treated Heathcare—14 Feb 18

"I was thinking I was on top of the world," Wiseman said. "I was keeping myself in shape. I was taking care of myself mentally and physically. My relationship was solid." Then, during a routine medical exam while serving in the military in California,

World#s Leading Health Organizations Release Third Edition of Widely Used Resource on Family Heathcare—13 Feb 18

Global Handbook Gives Health-Care Providers Accurate and Practical Guidance for Counseling Clients Family planning is considered a development "best buy" and a life-saving intervention for millions of women and girls. Crucial to the success of family

ไฟเซอร์ ประเทศไทย สนับสนุนงานประชุมวิชาการด้านโรคมะเร็ง Heathcare—12 Feb 18

แผนกมะเร็งวิทยาของบริษัท ไฟเซอร์ (ประเทศไทย) จำกัด (Pfizer Oncology) ให้การสนับสนุนการจัดงานประชุมวิชาการ 'The 5th Ramathibodi-Mayo Clinic Joint Conference: Best Practice in Oncology 2018' ช่วง Lunch Symposium' ในหัวข้อ Continuum of care for ALK positive

Berlinger Special AG: Uniform Security Standard for Doping Control Heathcare—05 Feb 18

The BEREG-KITs preferred by the International Olympic Committee (IOC) can be used throughout the coming 2018 Olympic Winter Games in PyeongChang. Their manufacturer Berlinger Special AG is also adding further security features to the product to enable